After exclusion of samples for technical reasons, such as incomplete bisulfite conversion or failed amplification, the methylation levels were analyzed for FBLN1 for 38 controls and 32 HCC patients from France and for 28 controls, 16 chronic liver disease patients and 22 HCC patients from Thailand, and for VIM for 31 controls and 21 HCC patients from France and for 30 controls, 15 chronic liver disease patients and 19 HCC patients from Thailand. The gene discussed is FBLN1; the disease is hepatocellular carcinoma.